Global Biologics CDMO Market (2022 Edition) - Analysis By Type (Mammalian, Non-Mammalian), Product Type (Biologics, Biosimilars), By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2021-2026)
Executive Summary
According to Azoth Analytics research report, the global Biologics CDMO Market was valued at USD 9.9 Billion in the year 2020. Growth opportunities for the Biologics CDMO market is attributed to the growth of geriatric population, rising technical advancements by the CDMO service providers, increasing trend of outsourcing the drug development processes in the world and increasing number of research and development activities by some of the key market players in the global platform. In addition, increasing per capita disposable income, rising global healthcare expenditure along with demand for new therapeutic drugs in the market is driving the Biologics CDMO market.
Moreover, with rising prevalence of diseases in the world, it is expected that there will be more demand for new drugs which is likely to push the growth of Biologics CDMOs. Also, rising number of pharmaceutical companies in the emerging economies, increasing demand for novel therapeutic applications along with high demand for biologics are the major factors propelling the market growth. Furthermore, increased outsourcing trend by small and large pharmaceutical companies provides a promising opportunity for contract development and manufacturing organizations (CDMOs).
The outbreak of COVID-19 will influence the biologics CDMO market in the forecast period as well. This is due to the demand for vaccines and therapeutic antibodies which is expected to continue for several years. In addition to the economic and social burden, the pandemic has prompted government bodies to increase funding for vaccine development on a global scale. With the on-going crisis, there has been an immense burden on the healthcare sector worldwide and has impacted the discovery, research and development of many medicines pushing the growth of Biologics CDMO industry further.
Scope of the Report
According to Azoth Analytics research report, the global Biologics CDMO Market was valued at USD 9.9 Billion in the year 2020. Growth opportunities for the Biologics CDMO market is attributed to the growth of geriatric population, rising technical advancements by the CDMO service providers, increasing trend of outsourcing the drug development processes in the world and increasing number of research and development activities by some of the key market players in the global platform. In addition, increasing per capita disposable income, rising global healthcare expenditure along with demand for new therapeutic drugs in the market is driving the Biologics CDMO market.
Moreover, with rising prevalence of diseases in the world, it is expected that there will be more demand for new drugs which is likely to push the growth of Biologics CDMOs. Also, rising number of pharmaceutical companies in the emerging economies, increasing demand for novel therapeutic applications along with high demand for biologics are the major factors propelling the market growth. Furthermore, increased outsourcing trend by small and large pharmaceutical companies provides a promising opportunity for contract development and manufacturing organizations (CDMOs).
The outbreak of COVID-19 will influence the biologics CDMO market in the forecast period as well. This is due to the demand for vaccines and therapeutic antibodies which is expected to continue for several years. In addition to the economic and social burden, the pandemic has prompted government bodies to increase funding for vaccine development on a global scale. With the on-going crisis, there has been an immense burden on the healthcare sector worldwide and has impacted the discovery, research and development of many medicines pushing the growth of Biologics CDMO industry further.
Scope of the Report
- The report presents the analysis Biologics CDMOs market for the historical period of 2016-2020 and the forecast period of 2021-2026.
- The report analyses the Biologics CDMOs Market by value (USD Billion)
- The report analyses the Biologics CDMOs Market by Type (Mammalian and Non-Mammalian))
- The report analyses the Biologics CDMOs Market by Product Type(Biologics and Biosimilars)
- The Global Biologics CDMOs Market has been analysed By Region (North America, Europe, Asia Pacific and LAMEA)
- The Global Biologics CDMOs Market has been analysed By Country (United States, Canada, Germany, France, United Kingdom, China, Japan, India, Australia and South Korea)
- The attractiveness of the market has been presented by region, by Type and By Product Type
- Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
- The report tracks competitive developments, strategies, mergers and acquisitions and new product development.
- The companies analysed in the report include Lonza Group AG, Samsung Biologics, AbbVie Inc., WuXi Biologics Inc., Toyobo Co. Ltd., AGC Inc., Thermo Fisher Scientific Inc., ICON Plc, Boehringer Ingelheim and Fujifilm Diosynth Biotechnologies
- Biologics CDMOs
- Healthcare and Pharmaceutical Companies
- Consulting and Advisory Firms
- Government and Policy Makers
- Regulatory Authorities
1. REPORT SCOPE AND METHODOLOGY
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. STRATEGIC RECOMMENDATIONS
3. GLOBAL BIOLOGICS CDMO MARKET: PRODUCT OUTLOOK
4. GLOBAL BIOLOGICS CDMO MARKET: SIZE AND FORECAST
4.1 Global Biologics CDMO Market Size, By Value, Year 2016-2026
5. GLOBAL BIOLOGICS CDMO MARKET SEGMENTATION – BY TYPE, BY PRODUCT TYPE
5.1 Competitive Scenario of Global Biologics CDMO Market: By Type
5.1.1 Mammalian – Market Size and Forecast (2016-2026)
5.1.2 Non-mammalian (Microbial)– Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Biologics CDMO Market: By Product Type
5.2.1 Biologics– Market Size and Forecast (2016-2026)
5.2.2 Biosimilar – Market Size and Forecast (2016-2026)
6. GLOBAL BIOLOGICS CDMO MARKET: REGIONAL ANALYSIS
6.1 Competitive Scenario of Global Biologics CDMO Market: By Region
7. NORTH AMERICA BIOLOGICS CDMO MARKET: AN ANALYSIS (2016-2026)
7.1North America Biologics CDMO Market: Size and Forecast (2016-2026)
7.2 North America Biologics CDMO Market – Prominent Companies
7.3 Market Segmentation by Type (Mammalian, Non-mammalian (Microbial))
7.4 Market Segmentation by Product Type (Biologics and Biosimilar)
7.5 North America Biologics CDMO Market: Country Analysis
7.6 Market Opportunity Chart of North America Biologics CDMO Market - By Country, By Value, 2026
7.7 Competitive Scenario of North America Biologics CDMO Market: By Country
7.8 United States Biologics CDMO Market: Size and Forecast (2016-2026), By Value
7.9 United States Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
7.10 Canada Biologics CDMO Market: Size and Forecast (2016-2026), By Value
7.11 Canada Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
Europe Biologics CDMO Market: An Analysis (2016-2026)
8.1 Europe Biologics CDMO Market: Size and Forecast (2016-2026), By Value
8.2 Europe Biologics CDMO Market – Prominent Companies
8.3 Market Segmentation by Type (Mammalian, Non-mammalian (Microbial))
8.4 Market Segmentation by Product Type (Biologics and Biosimilar)
8.5 Europe Biologics CDMO Market: Country Analysis
8.6 Market Opportunity Chart of Europe Biologics CDMO Market - By Country, By Value, 2026
8.7 Competitive Scenario of Europe Biologics CDMO Market: By Country
8.8 Germany Biologics CDMO Market: Size and Forecast (2016-2026), By Value
8.9 Germany Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
8.10 United Kingdom Biologics CDMO Market: Size and Forecast (2016-2026), By Value
8.11 United Kingdom Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
8.12 France Biologics CDMO Market: Size and Forecast (2016-2026), By Value
8.13 France Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
9. ASIA PACIFIC BIOLOGICS CDMO MARKET: AN ANALYSIS (2016-2026)
9.1 Asia Pacific Biologics CDMO Market: Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Biologics CDMO Market – Prominent Companies
9.3 Market Segmentation by Type (Mammalian, Non-mammalian (Microbial))
9.4 Market Segmentation by Product Type (Biologics and Biosimilar)
9.5 Asia Pacific Biologics CDMO Market: Country Analysis
9.6 Market Opportunity Chart of Asia Pacific Biologics CDMO Market - By Country, By Value, 2026
9.7 Competitive Scenario of Asia Pacific Biologics CDMO Market: By Country
9.8 China Biologics CDMO Market: Size and Forecast (2016-2026), By Value
9.9 China Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
9.10 Japan Biologics CDMO Market: Size and Forecast (2016-2026), By Value
9.11 Japan Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
9.12 India Biologics CDMO Market: Size and Forecast (2016-2026), By Value
9.13 India Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
9.14 Australia Biologics CDMO Market: Size and Forecast (2016-2026), By Value
9.15 Australia Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
9.16 South Korea Biologics CDMO Market: Size and Forecast (2016-2026), By Value
9.17 South Korea Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
10. GLOBAL BIOLOGICS CDMO MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Trends
11. MARKET ATTRACTIVENESS
11.1 Market Attractiveness Chart of Global Biologics CDMO Market – By Type, 2026
11.2 Market Attractiveness Chart of Global Biologics CDMO Market - By Product Type, 2026
11.3 Market Attractiveness Chart of Global Biologics CDMO Market - By Region, 2026
12. COMPETITIVE LANDSCAPE
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Market Share Analysis
13. COMPANY PROFILES
13.1 Lonza Group AG
13.2 Samsung Biologics
13.3 AbbVie Inc.
13.4 WuXi Biologics Inc.
13.5 Toyobo Co. Ltd.
13.6 AGC Inc.
13.7 Thermo Fisher Scientific Inc.
13.8 ICON Plc
13.9 Boehringer Ingelheim
13.10 Fujifilm Diosynth Biotechnologies
14. ABOUT US
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. STRATEGIC RECOMMENDATIONS
3. GLOBAL BIOLOGICS CDMO MARKET: PRODUCT OUTLOOK
4. GLOBAL BIOLOGICS CDMO MARKET: SIZE AND FORECAST
4.1 Global Biologics CDMO Market Size, By Value, Year 2016-2026
5. GLOBAL BIOLOGICS CDMO MARKET SEGMENTATION – BY TYPE, BY PRODUCT TYPE
5.1 Competitive Scenario of Global Biologics CDMO Market: By Type
5.1.1 Mammalian – Market Size and Forecast (2016-2026)
5.1.2 Non-mammalian (Microbial)– Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Biologics CDMO Market: By Product Type
5.2.1 Biologics– Market Size and Forecast (2016-2026)
5.2.2 Biosimilar – Market Size and Forecast (2016-2026)
6. GLOBAL BIOLOGICS CDMO MARKET: REGIONAL ANALYSIS
6.1 Competitive Scenario of Global Biologics CDMO Market: By Region
7. NORTH AMERICA BIOLOGICS CDMO MARKET: AN ANALYSIS (2016-2026)
7.1North America Biologics CDMO Market: Size and Forecast (2016-2026)
7.2 North America Biologics CDMO Market – Prominent Companies
7.3 Market Segmentation by Type (Mammalian, Non-mammalian (Microbial))
7.4 Market Segmentation by Product Type (Biologics and Biosimilar)
7.5 North America Biologics CDMO Market: Country Analysis
7.6 Market Opportunity Chart of North America Biologics CDMO Market - By Country, By Value, 2026
7.7 Competitive Scenario of North America Biologics CDMO Market: By Country
7.8 United States Biologics CDMO Market: Size and Forecast (2016-2026), By Value
7.9 United States Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
7.10 Canada Biologics CDMO Market: Size and Forecast (2016-2026), By Value
7.11 Canada Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
Europe Biologics CDMO Market: An Analysis (2016-2026)
8.1 Europe Biologics CDMO Market: Size and Forecast (2016-2026), By Value
8.2 Europe Biologics CDMO Market – Prominent Companies
8.3 Market Segmentation by Type (Mammalian, Non-mammalian (Microbial))
8.4 Market Segmentation by Product Type (Biologics and Biosimilar)
8.5 Europe Biologics CDMO Market: Country Analysis
8.6 Market Opportunity Chart of Europe Biologics CDMO Market - By Country, By Value, 2026
8.7 Competitive Scenario of Europe Biologics CDMO Market: By Country
8.8 Germany Biologics CDMO Market: Size and Forecast (2016-2026), By Value
8.9 Germany Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
8.10 United Kingdom Biologics CDMO Market: Size and Forecast (2016-2026), By Value
8.11 United Kingdom Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
8.12 France Biologics CDMO Market: Size and Forecast (2016-2026), By Value
8.13 France Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
9. ASIA PACIFIC BIOLOGICS CDMO MARKET: AN ANALYSIS (2016-2026)
9.1 Asia Pacific Biologics CDMO Market: Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Biologics CDMO Market – Prominent Companies
9.3 Market Segmentation by Type (Mammalian, Non-mammalian (Microbial))
9.4 Market Segmentation by Product Type (Biologics and Biosimilar)
9.5 Asia Pacific Biologics CDMO Market: Country Analysis
9.6 Market Opportunity Chart of Asia Pacific Biologics CDMO Market - By Country, By Value, 2026
9.7 Competitive Scenario of Asia Pacific Biologics CDMO Market: By Country
9.8 China Biologics CDMO Market: Size and Forecast (2016-2026), By Value
9.9 China Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
9.10 Japan Biologics CDMO Market: Size and Forecast (2016-2026), By Value
9.11 Japan Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
9.12 India Biologics CDMO Market: Size and Forecast (2016-2026), By Value
9.13 India Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
9.14 Australia Biologics CDMO Market: Size and Forecast (2016-2026), By Value
9.15 Australia Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
9.16 South Korea Biologics CDMO Market: Size and Forecast (2016-2026), By Value
9.17 South Korea Biologics CDMO Market Segmentation - By Type, By Product Type (2016-2026)
10. GLOBAL BIOLOGICS CDMO MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Trends
11. MARKET ATTRACTIVENESS
11.1 Market Attractiveness Chart of Global Biologics CDMO Market – By Type, 2026
11.2 Market Attractiveness Chart of Global Biologics CDMO Market - By Product Type, 2026
11.3 Market Attractiveness Chart of Global Biologics CDMO Market - By Region, 2026
12. COMPETITIVE LANDSCAPE
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Market Share Analysis
13. COMPANY PROFILES
13.1 Lonza Group AG
13.2 Samsung Biologics
13.3 AbbVie Inc.
13.4 WuXi Biologics Inc.
13.5 Toyobo Co. Ltd.
13.6 AGC Inc.
13.7 Thermo Fisher Scientific Inc.
13.8 ICON Plc
13.9 Boehringer Ingelheim
13.10 Fujifilm Diosynth Biotechnologies
14. ABOUT US
LIST OF FIGURES
Global Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
Source of Pipeline Innovation Shifting Increasingly Towards Biotech, 2015-2019
World’s leading causes of death (in millions), 2019
World Population 65 Years & Above (% of Total), 2015-2019
Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Estimated number of new cases in 2020, worldwide, both sexes, all ages
Global Biologics CDMO Market-By Type Market Share, 2020 & 2026
Global Biologics CDMO Market- By Mammalian, By Value (USD Billion), 2016-2026
Global Biologics CDMO Market- By Non-mammalian (Microbial), By Value (USD Billion), 2016-2026
Global Biologics CDMO Market- By Product Type Market Share, 2020 & 2026
Global Biologics CDMO Market- By Biologics, By Value (USD Billion), 2016-2026
Global Biologics CDMO Market- By Biosimilar, By Value (USD Billion), 2016-2026
Global Biologics CDMO Market- By Region Market Share, 2020 & 2026
North America Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
North America Population 65 Years & Above (% of Total), 2015-2019
North America Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
North America Urban population, 2015-2018 (In %)
North America Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
North America Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Market Opportunity Chart of North America Biologics CDMO Market- By Country, By Value (Year 2016-2026)
North America Biologics CDMO Market- By Country Market Share, 2020 & 2026
United States Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
United State year-on-year growth of Biologics CDMO (in %), (2020-2026)
United State population aged 65 and above, (in % of total population), 2016-2020
United State health expenditure (% of GDP), 2013-2018
United State Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
United State Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Canada Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
Canada population aged 65 and above (% of total population), 2016-2020
Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Canada Urban population, 2016-2020 (In % of total population)
Canada Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
Canada Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Europe Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
Europe current health expenditure (% of GDP), (2014-2018)
Europe population aged 65 and above (% of total population), 2020
Europe urban population (as % of total population), 2020
Europe Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
Europe Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Market Opportunity Chart of Europe Biologics CDMO Market- By Country, By Value (Year 2016-2026)
Europe Biologics CDMO Market- By Country Market Share, 2020 & 2026
Germany Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
Germany current health expenditure (% of GDP), (2014-2018)
Germany population aged 65 and above (% of total population), 2016-2020
Germany urban population (% of total population), 2016-2019
Germany Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
Germany Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
United Kingdom Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
United Kingdom current health expenditure (% of GDP), (2014-2018)
United Kingdom population aged 65 and above (% of total population), 2016-2020
United Kingdom urban population (in millions), 2016-2020
United Kingdom Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
United Kingdom Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
France Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
France current health expenditure (% of GDP), (2014-2018)
France urban population (% of total population), 2016-2020
France population aged 65 and above (% of total population), 2016-2020
France Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
France Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Asia Pacific Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
Asia Pacific urban population (% of total population), 2016-2020
Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Asia Pacific population aged 65 years and above (% of total population), 2016-2020
Asia Pacific Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
Asia Pacific Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Market Opportunity Chart of APAC Biologics CDMO Market- By Country, By Value (Year-2026)
APAC Biologics CDMO Market- By Country Market Share, 2020 & 2026
China Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
China total population in billions, 2016-2020
China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
China urban population (% of total population), 2016-2020
China Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
China Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Japan Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
Japan population above 65 years (% of total population), 2016-2020
Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
Japan urban population (in millions), 2016-2020
Japan Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
Japan Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
India Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
India Current Healthcare Expenditure (% of GDP), 2015-2018
India population (in billions), 2016-2020
India urban population (% of total population), 2015-2019
India Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
India Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Australia Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
Australia current health expenditure (% of GDP), (2014-2018)
Australia population aged 65 and above (% of total population), 2016-2020
Australia urban population (% of total population), 2016-2020
Australia Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
Australia Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
South Korea Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
South Korea current health expenditure (% of GDP), (2014-2018)
South Korea population aged 65 and above (% of total population), 2016-2020
South Korea urban population (% of total population), 2016-2020
South Korea Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
South Korea Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Market Attractiveness Chart of Global Biologics CDMO Market- By Type (Year-2016-2026)
Market Attractiveness Chart of Global Biologics CDMO Market- By Product Type (Year 2016-2026)
Market Attractiveness Chart of Global Biologics CDMO Market- By Region (Year 2016-2026)
Global Biologics CDMO players market share (%), 2020
Lonza Group AG Annual Sales Revenue (USD Million), 2016-2020
Lonza Group AG. Net Income (USD Million), 2016-2020
Lonza Group AG. Sales Revenue Split by business segment, 2020 (%)
Lonza Group AG. Sales Revenue Split by geographical segment, 2020 (%)
Samsung Biologics Annual Sales Revenue (USD Million), 2016-2020
Samsung Biologics Net Income (USD Million), 2016-2020
Samsung Biologics Sales Revenue Split by business segment, 2020 (%)
Samsung Biologics Sales Revenue Split by geographical segment, 2020 (%)
AbbVie Inc. Annual Sales Revenue (USD Million), 2016-2020
AbbVie Inc. Net Income (USD Million), 2016-2020
AbbVie Inc. Sales Revenue Split, By Business Segment (%), FY2020
AbbVie Inc. Sales Revenue Split, By Geography Segment (%), FY2020
WuXi Biologics Inc. Annual Sales Revenue (USD Million), 2016-2020
WuXi Biologics Inc. Annual Net Income (USD Million), 2016-2020
WuXi Biologics Inc. Sales Revenue Split, By Business Segment (USD Million), FY2020
WuXi Biologics Inc. Sales Revenue Split, By Geography Segment (%), FY2020
Toyobo Co. Ltd. Annual Sales Revenue (USD Million), 2016-2020
Toyobo Co. Ltd. Annual Net Income (USD Million), 2016-2020
Toyobo Co. Ltd. Sales Revenue Split, By Business Segment (USD Million), FY2020
Toyobo Co. Ltd. Sales Revenue Split, By Geography Segment (%), FY2020
AGC Inc. Sales Revenues, 2016-2020 (USD Million)
AGC Inc. Net Income, 2016-2020 (USD Million)
AGC Inc. Sales Revenue Split, By Business Segment (%), FY2020
AGC Inc. Sales Revenue Split, By Business Segment (%), FY2019
Thermo Fisher Scientific Inc. Sales Revenues, 2016-2020 (USD Million)
Thermo Fisher Scientific Inc. Net Income, 2016-2020 (USD Million)
Thermo Fisher Scientific Inc. sales Revenues, By Business Segment (%), FY2020
Thermo Fisher Scientific Inc. sales Revenue, By Geographical Segment (%), FY2020
ICON Plc Sales Revenues, 2016-2020 (USD Million)
ICON Plc Net Income, 2016-2020 (USD Million)
ICON Plc Sales Revenue Split, By Geography Segment (%), FY2020
ICON Plc Sales Revenue Split, By Geography Segment (%), FY2019
Boehringer Ingelheim Revenues, 2016-2020 (USD Million)
Boehringer Ingelheim Net Income/Loss, 2016-2020 (USD Million)
Boehringer Ingelheim Sales Revenue Split, By Business Segment (%), FY2020
Boehringer Ingelheim Sales Revenue Split, By Geography Segment (%), FY2020
Fujifilm Annual Sales Revenue, 2016-2020 (USD Million)
Fujifilm Net Income, 2016-2020 (USD Million)
Fujifilm Sales Revenue, By Business Segment (%), FY2020
Fujifilm Sales Revenue, By Geographical Segment (%), FY2020
Global Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
Source of Pipeline Innovation Shifting Increasingly Towards Biotech, 2015-2019
World’s leading causes of death (in millions), 2019
World Population 65 Years & Above (% of Total), 2015-2019
Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Estimated number of new cases in 2020, worldwide, both sexes, all ages
Global Biologics CDMO Market-By Type Market Share, 2020 & 2026
Global Biologics CDMO Market- By Mammalian, By Value (USD Billion), 2016-2026
Global Biologics CDMO Market- By Non-mammalian (Microbial), By Value (USD Billion), 2016-2026
Global Biologics CDMO Market- By Product Type Market Share, 2020 & 2026
Global Biologics CDMO Market- By Biologics, By Value (USD Billion), 2016-2026
Global Biologics CDMO Market- By Biosimilar, By Value (USD Billion), 2016-2026
Global Biologics CDMO Market- By Region Market Share, 2020 & 2026
North America Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
North America Population 65 Years & Above (% of Total), 2015-2019
North America Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
North America Urban population, 2015-2018 (In %)
North America Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
North America Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Market Opportunity Chart of North America Biologics CDMO Market- By Country, By Value (Year 2016-2026)
North America Biologics CDMO Market- By Country Market Share, 2020 & 2026
United States Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
United State year-on-year growth of Biologics CDMO (in %), (2020-2026)
United State population aged 65 and above, (in % of total population), 2016-2020
United State health expenditure (% of GDP), 2013-2018
United State Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
United State Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Canada Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
Canada population aged 65 and above (% of total population), 2016-2020
Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Canada Urban population, 2016-2020 (In % of total population)
Canada Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
Canada Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Europe Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
Europe current health expenditure (% of GDP), (2014-2018)
Europe population aged 65 and above (% of total population), 2020
Europe urban population (as % of total population), 2020
Europe Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
Europe Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Market Opportunity Chart of Europe Biologics CDMO Market- By Country, By Value (Year 2016-2026)
Europe Biologics CDMO Market- By Country Market Share, 2020 & 2026
Germany Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
Germany current health expenditure (% of GDP), (2014-2018)
Germany population aged 65 and above (% of total population), 2016-2020
Germany urban population (% of total population), 2016-2019
Germany Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
Germany Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
United Kingdom Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
United Kingdom current health expenditure (% of GDP), (2014-2018)
United Kingdom population aged 65 and above (% of total population), 2016-2020
United Kingdom urban population (in millions), 2016-2020
United Kingdom Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
United Kingdom Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
France Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
France current health expenditure (% of GDP), (2014-2018)
France urban population (% of total population), 2016-2020
France population aged 65 and above (% of total population), 2016-2020
France Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
France Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Asia Pacific Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
Asia Pacific urban population (% of total population), 2016-2020
Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Asia Pacific population aged 65 years and above (% of total population), 2016-2020
Asia Pacific Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
Asia Pacific Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Market Opportunity Chart of APAC Biologics CDMO Market- By Country, By Value (Year-2026)
APAC Biologics CDMO Market- By Country Market Share, 2020 & 2026
China Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
China total population in billions, 2016-2020
China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
China urban population (% of total population), 2016-2020
China Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
China Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Japan Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
Japan population above 65 years (% of total population), 2016-2020
Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
Japan urban population (in millions), 2016-2020
Japan Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
Japan Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
India Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
India Current Healthcare Expenditure (% of GDP), 2015-2018
India population (in billions), 2016-2020
India urban population (% of total population), 2015-2019
India Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
India Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Australia Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
Australia current health expenditure (% of GDP), (2014-2018)
Australia population aged 65 and above (% of total population), 2016-2020
Australia urban population (% of total population), 2016-2020
Australia Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
Australia Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
South Korea Biologics CDMO Market Size, By Value, 2016-2026 (USD Billion)
South Korea current health expenditure (% of GDP), (2014-2018)
South Korea population aged 65 and above (% of total population), 2016-2020
South Korea urban population (% of total population), 2016-2020
South Korea Biologics CDMO Market- By Type, By Value (USD Billion), 2016-2026
South Korea Biologics CDMO Market- By Product Type, By Value (USD Billion), 2016-2026
Market Attractiveness Chart of Global Biologics CDMO Market- By Type (Year-2016-2026)
Market Attractiveness Chart of Global Biologics CDMO Market- By Product Type (Year 2016-2026)
Market Attractiveness Chart of Global Biologics CDMO Market- By Region (Year 2016-2026)
Global Biologics CDMO players market share (%), 2020
Lonza Group AG Annual Sales Revenue (USD Million), 2016-2020
Lonza Group AG. Net Income (USD Million), 2016-2020
Lonza Group AG. Sales Revenue Split by business segment, 2020 (%)
Lonza Group AG. Sales Revenue Split by geographical segment, 2020 (%)
Samsung Biologics Annual Sales Revenue (USD Million), 2016-2020
Samsung Biologics Net Income (USD Million), 2016-2020
Samsung Biologics Sales Revenue Split by business segment, 2020 (%)
Samsung Biologics Sales Revenue Split by geographical segment, 2020 (%)
AbbVie Inc. Annual Sales Revenue (USD Million), 2016-2020
AbbVie Inc. Net Income (USD Million), 2016-2020
AbbVie Inc. Sales Revenue Split, By Business Segment (%), FY2020
AbbVie Inc. Sales Revenue Split, By Geography Segment (%), FY2020
WuXi Biologics Inc. Annual Sales Revenue (USD Million), 2016-2020
WuXi Biologics Inc. Annual Net Income (USD Million), 2016-2020
WuXi Biologics Inc. Sales Revenue Split, By Business Segment (USD Million), FY2020
WuXi Biologics Inc. Sales Revenue Split, By Geography Segment (%), FY2020
Toyobo Co. Ltd. Annual Sales Revenue (USD Million), 2016-2020
Toyobo Co. Ltd. Annual Net Income (USD Million), 2016-2020
Toyobo Co. Ltd. Sales Revenue Split, By Business Segment (USD Million), FY2020
Toyobo Co. Ltd. Sales Revenue Split, By Geography Segment (%), FY2020
AGC Inc. Sales Revenues, 2016-2020 (USD Million)
AGC Inc. Net Income, 2016-2020 (USD Million)
AGC Inc. Sales Revenue Split, By Business Segment (%), FY2020
AGC Inc. Sales Revenue Split, By Business Segment (%), FY2019
Thermo Fisher Scientific Inc. Sales Revenues, 2016-2020 (USD Million)
Thermo Fisher Scientific Inc. Net Income, 2016-2020 (USD Million)
Thermo Fisher Scientific Inc. sales Revenues, By Business Segment (%), FY2020
Thermo Fisher Scientific Inc. sales Revenue, By Geographical Segment (%), FY2020
ICON Plc Sales Revenues, 2016-2020 (USD Million)
ICON Plc Net Income, 2016-2020 (USD Million)
ICON Plc Sales Revenue Split, By Geography Segment (%), FY2020
ICON Plc Sales Revenue Split, By Geography Segment (%), FY2019
Boehringer Ingelheim Revenues, 2016-2020 (USD Million)
Boehringer Ingelheim Net Income/Loss, 2016-2020 (USD Million)
Boehringer Ingelheim Sales Revenue Split, By Business Segment (%), FY2020
Boehringer Ingelheim Sales Revenue Split, By Geography Segment (%), FY2020
Fujifilm Annual Sales Revenue, 2016-2020 (USD Million)
Fujifilm Net Income, 2016-2020 (USD Million)
Fujifilm Sales Revenue, By Business Segment (%), FY2020
Fujifilm Sales Revenue, By Geographical Segment (%), FY2020
